Cargando…

Namodenoson Inhibits the Growth of Pancreatic Carcinoma via Deregulation of the Wnt/β-catenin, NF-κB, and RAS Signaling Pathways

Namodenoson, an A(3) adenosine receptor (A(3)AR) agonist, is currently being used in a phase III trial in advanced liver cancer. We examined the anti-growth effect of namodenoson on pancreatic carcinoma cells and investigated the molecular mechanism involved. BxPC-3 pancreatic carcinoma cells were c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Itzhak, Inbal, Bareket-Samish, Avital, Fishman, Pnina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669398/ https://www.ncbi.nlm.nih.gov/pubmed/38002266 http://dx.doi.org/10.3390/biom13111584

Ejemplares similares

Randomised clinical trial: A phase 2 double‐blind study of namodenoson in non‐alcoholic fatty liver disease and steatohepatitis
por: Safadi, Rifaat, et al.
Publicado: (2021)

The A3 adenosine receptor agonist, namodenoson, ameliorates non-alcoholic steatohepatitis in mice
por: Fishman, Pnina, et al.
Publicado: (2019)

Namodenoson in Advanced Hepatocellular Carcinoma and Child–Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial
por: Stemmer, Salomon M., et al.
Publicado: (2021)

Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepatoprotective effects
por: Fishman, Pnina, et al.
Publicado: (2023)

Interaction between Wnt/β-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of β-catenin and RAS by targeting the Wnt/β-catenin pathway
por: Jeong, Woo-Jeong, et al.
Publicado: (2018)

Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling
por: Herbst, Andreas, et al.
Publicado: (2014)

Infectious Agents Induce Wnt/β-Catenin Pathway Deregulation in Primary Liver Cancers
por: Catalano, Teresa, et al.
Publicado: (2023)

Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation
por: Ma, Bin, et al.
Publicado: (2016)

Hormone-Replacement Therapy and Its Association with Breast Cancer Subtypes: A Large Retrospective Cohort Study
por: Rosenberg, Vered, et al.
Publicado: (2021)

Ectodysplasin/NF-κB Promotes Mammary Cell Fate via Wnt/β-catenin Pathway
por: Voutilainen, Maria, et al.
Publicado: (2015)

Neuroglobin Regulates Wnt/β-Catenin and NFκB Signaling Pathway through Dvl1
por: Xun, Yu, et al.
Publicado: (2018)

Morusin alleviates mycoplasma pneumonia via the inhibition of Wnt/β-catenin and NF-κB signaling
por: Chen, Cunrong, et al.
Publicado: (2019)

Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A(3) Adenosine Receptor Agonist Piclidenoson
por: Cohen, Shira, et al.
Publicado: (2018)

An LRP5 Receptor with Internal Deletion in Hyperparathyroid Tumors with Implications for Deregulated WNT/β-Catenin Signaling
por: Björklund, Peyman, et al.
Publicado: (2007)

Destabilization of β-catenin and RAS by targeting the Wnt/β-catenin pathway as a potential treatment for triple-negative breast cancer
por: Ryu, Won-Ji, et al.
Publicado: (2020)

Costunolide inhibits matrix metalloproteinases expression and osteoarthritis via the NF-κB and Wnt/β-catenin signaling pathways
por: He, Yuzhe, et al.
Publicado: (2019)

Epigenetic deregulation of MLF1 drives intrahepatic cholangiocarcinoma progression through EGFR/AKT and Wnt/β-catenin signaling
por: Tang, Zengwei, et al.
Publicado: (2023)

RAS MAPK inhibitors deregulation in leukemia
por: Pasmant, Eric, et al.
Publicado: (2015)

Wnt/β‐catenin/RAS signaling mediates age‐related renal fibrosis and is associated with mitochondrial dysfunction
por: Miao, Jinhua, et al.
Publicado: (2019)

Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines
por: Schmidtova, Silvia, et al.
Publicado: (2021)

WNT5A, β-catenin and SUFU expression patterns, and the significance of microRNA deregulation in placentas with intrauterine growth restriction
por: Sola, Ida Marija, et al.
Publicado: (2022)

Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance
por: Ram Makena, Monish, et al.
Publicado: (2019)

Maternal Wnt/β-Catenin Signaling Coactivates Transcription through NF-κB Binding Sites during Xenopus Axis Formation
por: Armstrong, Neil J., et al.
Publicado: (2012)

TNF-α promotes the malignant transformation of intestinal stem cells through the NF-κB and Wnt/β-catenin signaling pathways
por: Zhao, Xiaopeng, et al.
Publicado: (2020)

LGK974 suppresses lipopolysaccharide-induced endotoxemia in mice by modulating the crosstalk between the Wnt/β-catenin and NF-κB pathways
por: Jang, Jaewoong, et al.
Publicado: (2021)

LRFN2 binding to NMDAR inhibits the progress of ESCC via regulating the Wnt/β‐Catenin and NF‐κB signaling pathway
por: Zhou, Yu, et al.
Publicado: (2022)

Corrigendum to: Wnt/β‐catenin/RAS signaling mediates age‐related renal fibrosis and is associated with mitochondrial dysfunction
Publicado: (2023)

Ras-Mediated Deregulation of the Circadian Clock in Cancer
por: Relógio, Angela, et al.
Publicado: (2014)

Nanosecond Pulsed Electric Field Inhibits Cancer Growth Followed by Alteration in Expressions of NF-κB and Wnt/β-Catenin Signaling Molecules
por: Ren, Zhigang, et al.
Publicado: (2013)

Excessive Activation of TLR4/NF-κB Interactively Suppresses the Canonical Wnt/β-catenin Pathway and Induces SANFH in SD Rats
por: Pei, Junpeng, et al.
Publicado: (2017)

PITX2 in pancreatic stellate cells promotes EMT in pancreatic cancer cells via the Wnt/β-catenin pathway: PITX2 promotes pancreatic cancer progression via Wnt/β-catenin pathway
por: Wu, Di, et al.
Publicado: (2023)

WNKs in Wnt/β-catenin signaling
por: Serysheva, Ekatherina, et al.
Publicado: (2014)

Wnt/β-Catenin Signaling and Obesity
por: Chen, Na, et al.
Publicado: (2018)

Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathway
por: Liu, Yan-Qiu, et al.
Publicado: (2016)

Gastrodin Improves Cognitive Dysfunction in REM Sleep-Deprived Rats by Regulating TLR4/NF-κB and Wnt/β-Catenin Signaling Pathways
por: Liu, Bo, et al.
Publicado: (2023)

WNT7B mediates autocrine Wnt/β-catenin signaling and anchorage-independent growth in pancreatic adenocarcinoma
por: Arensman, Michael D., et al.
Publicado: (2013)

Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling
por: Lin, Chung-Ming, et al.
Publicado: (2017)

Riluzole regulates pancreatic cancer cell metabolism by suppressing the Wnt-β-catenin pathway
por: Roy, Sanjit K., et al.
Publicado: (2022)

Extract of Corallodiscus flabellata attenuates renal fibrosis in SAMP8 mice via the Wnt/β-catenin/RAS signaling pathway
por: Cao, Bing, et al.
Publicado: (2022)

Wnt-Signaling Inhibitor Wnt-C59 Suppresses the Cytokine Upregulation in Multiple Organs of Lipopolysaccharide-Induced Endotoxemic Mice via Reducing the Interaction between β-Catenin and NF-κB
por: Jang, Jaewoong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nn4n22h3rkaheott8qnthllu2j